Citadel Advisors’s Clene CLNN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-5,035
Closed -$26.7K 14588
2024
Q4
$26.7K Buy
+5,035
New +$25.3K ﹤0.01% 12970
2024
Q3
Sell
-5,055
Closed -$36K 14324
2024
Q2
$36K Sell
5,055
-5
-0.1% -$37 ﹤0.01% 12092
2024
Q1
$43K Sell
5,060
-1,290
-20% -$11.2K ﹤0.01% 12321
2023
Q4
$37.7K Sell
6,350
-60
-0.9% -$523 ﹤0.01% 12063
2023
Q3
$63.6K Sell
6,410
-640
-9% -$8.87K ﹤0.01% 11454
2023
Q2
$124K Buy
7,050
+4,430
+169% +$86.5K ﹤0.01% 10602
2023
Q1
$59.2K Buy
2,620
+1,035
+65% +$26.8K ﹤0.01% 11945
2022
Q4
$31.7K Sell
1,585
-23,075
-94% -$535K ﹤0.01% 12671
2022
Q3
$1.38M Buy
+24,660
New +$1.63M ﹤0.01% 6317

Other funds holding CLNN

Citadel Advisors's CLNN Position: Q1 2025 in Review

Citadel Advisors sold out of Clene (CLNN) in Q1 2025, closing a stake of 20,835 shares — an estimated $111K sold.

Citadel Advisors first reported a position in CLNN in Q1 2021 and held it in 11 quarters. The position peaked at $1.63M in Q2 2023. 24 funds tracked by Wall St. Rank hold CLNN as of Q1 2025.

  • Citadel Advisors reported no remaining Clene position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 20,835 Clene shares in Q1 2025, an estimated $111K.
  • Citadel Advisors first reported a position in Clene in Q1 2021 and held it in 11 quarters.
  • Citadel Advisors's Clene position peaked at $1.63M in Q2 2023.
  • 24 funds tracked by Wall St. Rank held Clene as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.